Market Research Report
Pulse Oximeters Market Size, Share & Trends Analysis Report By Type (Fingertip, Handheld), By End Use (Hospitals & Healthcare Facilities, Homecare), By Region, And Segment Forecasts, 2019 - 2025
|Published by||Grand View Research, Inc.||Product code||478617|
|Published||Content info||100 Pages
Delivery time: 2-3 business days
|Pulse Oximeters Market Size, Share & Trends Analysis Report By Type (Fingertip, Handheld), By End Use (Hospitals & Healthcare Facilities, Homecare), By Region, And Segment Forecasts, 2019 - 2025|
|Published: February 8, 2019||Content info: 100 Pages||
The global pulse oximeters market size is expected to reach USD 2.8 billion by 2025, based on a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.3% during the forecast period. The growth can be attributed to high prevalence of target diseases, such as Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, cardiac arrhythmia, and ischemic conditions. Pulse oximetry is mandatory for newborn screening in almost 43 states in the U.S. It is also gaining roots in other parts of the world as it helps in detection of Congenital Heart Defect (CHD).
Technological advancements in pulse oximeters to make the devices more efficient and user-friendly can boost the demand. For instance, in August 2015, Nonin Medical, Inc. launched NoninConnect Model 3230, a wireless fingertip oximeter that can be operated via Bluetooth. The product has low power usage and was intended for the identification of early intervention patients with respiratory conditions, such as COPD.
Asia Pacific is anticipated to register the fastest growth over the forthcoming years. Increasing investments from industry players is the key driver for the regional growth. In January 2017, Masimo launched two patient monitoring products in India, namely, Rad-97 Pulse-CO Oximeter and SedLine Brain Function Monitoring. These products are expected to improve the patient monitoring capabilities of clinicians in the region.
Product innovation and R&D are some of the major strategies adopted by the key companies operating in the market for pulse oximeters. For instance, in September 2018, Masimo announced the FDA approval of rainbow Acoustic Monitoring RAS-45 Sensor, a noninvasive respiration rate measurement system for infant and neonatal patients. In July 2018, the company launched the Vital Signs Check Application- a comprehensive patient data collection application for the Masimo Root patient connectivity and monitoring platform.
Some of the key players operating in the pulse oximeters market are: Covidien; CareFusion Corp; GE Healthcare; Koninklijke Philips N.V.; Masimo; CAS Medical Systems, Inc.; Opto Circuits India Ltd.; Nonin Medical, Inc.; Smiths Medical; Welch Allyn; Spacelabs Healthcare; Zensorium; Meditech Equipment Co. Ltd.; and Nihon Kohden Corporation.